🔎 Trials Near Me

Utama › Kanser Pundi Kencing › California › Los Angeles

Kajian klinikal Kanser Pundi Kencing di Los Angeles, CA

24 kajian untuk Kanser Pundi Kencing sedang mencari peserta di lokasi dalam dan sekitar Los Angeles (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

Mengambil pesertaFasa 2
  • Los Angeles General Medical Center, Los Angeles
  • USC / Norris Comprehensive Cancer Center, Los Angeles
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Okt 2026 · NCT06770582

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Mengambil pesertaFasa 1
  • UCLA Department of Medicine-Hematology/Oncology, Los Angeles
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06465069

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

Mengambil pesertaFasa 2
  • USC Norris Comprehensive Cancer Center ( Site 0123), Los Angeles
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06833073

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

Mengambil pesertaFasa 2
  • Los Angeles General Medical Center, Los Angeles
  • USC / Norris Comprehensive Cancer Center, Los Angeles
  • Cedars-Sinai Medical Center, Los Angeles
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07061964

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

Mengambil pesertaFasa 1
  • Ronald Reagan UCLA Medical Center, Los Angeles
  • UCLA Department of Medicine-Hematology/Oncology, Los Angeles
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07090499

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Mengambil pesertaFasa 2
  • Keck Medicine of USC Koreatown, Los Angeles
  • Los Angeles General Medical Center, Los Angeles
  • USC / Norris Comprehensive Cancer Center, Los Angeles
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT03866382

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

Mengambil pesertaFasa 1/2
  • START Los Angeles, LLC, Los Angeles
  • Los Angeles Cancer Network - Century City, Los Angeles
  • (IRB# 26-0433) Ronald Reagan UCLA Medical Center, Drug Information Center, Los Angeles
  • dan 1 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07421700

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Mengambil pesertaFasa 3
  • TRIO-US (Translational Research in Oncology-US), Los Angeles
  • UCLA Hematology/Oncology - Santa Monica, Los Angeles
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07218380

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

Mengambil pesertaFasa 1
  • USC/Norris Comprehensive Cancer Center, Los Angeles
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT07217171

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

Mengambil pesertaFasa 2/3
  • Research Site, Los Angeles
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT07129993

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

Mengambil pesertaFasa 1
  • University of California, Los Angeles (UCLA) - Division of Hematology-Oncology, Los Angeles
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT05614739

A Study of MGC026 in Participants With Advanced Solid Tumors

Mengambil pesertaFasa 1
  • The Angeles Clinic and Research Institute, Los Angeles
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Ogo 2026 · NCT06242470

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

Mengambil pesertaFasa 1/2
  • USC/Norris Comprehensive Cancer Center, Los Angeles
  • Tower Urology, Los Angeles
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Ogo 2026 · NCT04752722

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

Mengambil pesertaFasa 2
  • UCLA Downtown Los Angeles Primary & Specialty Care, Los Angeles
  • Kaiser Permanente Los Angeles Medical Offices, Los Angeles
  • Kaiser Permanente West Los Angeles Medical Center, Los Angeles
  • dan 6 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Jul 2026 · NCT04879329

A First in Human Study of PLT012 in Participants With Solid Tumor Cancers

Mengambil pesertaFasa 1
  • USC Norris Comprehensive Cancer Center, Los Angeles
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Jul 2026 · NCT07337525

Predicting BCG Response

Mengambil pesertaKajian pemerhatian
  • Cedars-Sinai Medical Center, Los Angeles
  • UCLA, Los Angeles
Umur 18 hingga 90 · Semua jantina · Dikemas kini 6 Jul 2026 · NCT04564781

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Mengambil pesertaFasa 1
  • Ronald Reagan UCLA Medical Center, Los Angeles
  • The Regents of the University of California, Los Angeles
  • UCLA Department of Medicine-Hematology/Oncology, Los Angeles
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Jul 2026 · NCT04389632

Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.

Mengambil peserta
  • Urology Group of Southern California, Los Angeles
  • Comprehensive Urology, Los Angeles
Umur 18 hingga 88 · Semua jantina · Dikemas kini 2 Jul 2026 · NCT06394869

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

Mengambil pesertaFasa 1
  • USC - Norris Comprehensive Cancer Center, Los Angeles
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Feb 2026 · NCT06778863

A Novel Multiplex ELISA Assay for Surveilling Patients With History of Bladder Cancer

Mengambil pesertaKajian pemerhatian
  • Cedars-Sinai Medical Center, Los Angeles
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Feb 2026 · NCT03193515

A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer

Mengambil pesertaKajian pemerhatian
  • Cedars-Sinai Medical Center, Los Angeles
  • UCLA Medical Center, Los Angeles
Umur 18 hingga 90 · Semua jantina · Dikemas kini 4 Feb 2026 · NCT03193541

Blue Light Cystoscopy With Cysview® Registry

Mengambil pesertaKajian pemerhatian
  • USC/Norris Comprehensive Cancer Center, Los Angeles
  • University of California Los Angeles, Los Angeles
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Dis 2025 · NCT02660645

Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy

Mengambil peserta
  • Cedars-Sinai Medical Center (CSMC), Los Angeles
  • University of California Los Angeles, Los Angeles
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Ogo 2025 · NCT04442724

Deceased Donor Bladder or Combined Kidney-bladder Transplantation: a Phase 0 First-in-human Study

Mengambil peserta
  • UCLA, Los Angeles
Umur 18 hingga 70 · Semua jantina · Dikemas kini 12 Feb 2025 · NCT06337942

Kajian Kanser Pundi Kencing di bandar lain

Kajian lain di Los Angeles

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.